Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-11 BAKER BROS. ADVISORS LP Director Purchase · 2026 $0.0001 Prefunded Warrants +126,394 $12.06 $1.5M 126,394
2026-08-11 BAKER BROS. ADVISORS LP Director Purchase · 2026 $0.0001 Prefunded Warrants +2,609,946 $12.06 $31.5M 2,609,946
2026-04-01 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy)uy) +44,500 44,500
2026-04-01 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy)uy) +44,500 44,500
2025-03-05 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy)uy) +64,000 64,000
2025-03-05 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy)uy) +64,000 64,000

Page 1 of 1 · 6 trades